NDC 73043-093-01 - Isosulfan Blue
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73043-093
- Requested NDC
- 73043-093-01
- Package NDCs from labels
- 73043-093-01, 73043-093-06
- Manufacturer
- Devatis, Inc. | SABA Ilac Sanayii ve Ticaret A.S. | DEVA Holding A.S.
- Effective date
- 2026-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Isosulfan Blue | Devatis, Inc. | SABA Ilac Sanayii ve Ticaret A.S. | DEVA Holding A.S. | 2026-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 98315c6e-308d-423b-a046-4be1f54d30ae | 2026-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION, | Amneal Pharmaceuticals Private Limited | 125121b8-bc4c-44ee-906e-e72f652a5aa6 | 2026-09-01 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Potassium Phosphates | POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC | CIVICA, INC. | f7702b2f-d0d1-4696-896d-571607fc0dc8 | 2026-07-10 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| Isosulfan Blue | ISOSULFAN BLUE | Devatis, Inc. | aa6260da-0acd-4552-a215-07df8da1031c | 2026-07-01 | Warnings, Adverse reactions | ANDA210714 73043-093-06 73043-093-01 73043-093 73043009301 2b782bc5-e7fb-48de-99fe-d17ef2cef094 aa6260da-0acd-4552-a215-07df8da1031c 39N9K8S2A4 |
| Isosulfan Blue | ISOSULFAN BLUE | Somerset Therapeutics, LLC | a4c7400a-ff36-4a76-aa84-7f91e303f937 | 2026-06-24 | Warnings, Adverse reactions | 39N9K8S2A4 |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 593YOG76RN | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 593YOG76RN | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 593YOG76RN | |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Hospira, Inc. | 6f044d16-295e-43ff-72a3-b045c387bc5c | 2026-05-11 | Warnings, Adverse reactions | 593YOG76RN |
| Isosulfan blue | ISOSULFAN BLUE | Novadoz Pharmaceuticals LLC | 4b7e84ee-f3ba-4b80-86d3-f4debe6a2eca | 2026-04-29 | Warnings, Adverse reactions | 39N9K8S2A4 |
| Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | b01eac95-dbe3-4b21-a922-187e0fc8ad23 | 2026-04-07 | Adverse reactions | 4J9FJ0HL51 593YOG76RN |
| PHOSPHA 250 NEUTRAL | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | 9432adfc-6add-4ab4-ae93-2e2daf348be2 | 2026-03-25 | Adverse reactions | 4J9FJ0HL51 593YOG76RN |
| POTASSIUM PHOSPHATES | POTASSIUM PHOSPHATES | GLENMARK PHARMACEUTICALS INC., USA | 70c7710c-a354-4941-bd46-e64d6ea6b5dc | 2026-03-20 | Warnings, Adverse reactions | 4J9FJ0HL51 |
| SODIUM PHOSPHATES | SODIUM PHOSPHATES | GLENMARK PHARMACEUTICALS INC., USA | c968f70b-a670-4aef-a7e0-89468ad62d9c | 2026-03-12 | Warnings, Adverse reactions | 593YOG76RN |
| SODIUM PHOSPHATES | SODIUM PHOSPHATES | Caplin Steriles Limited | 46de992b-5fc8-4dad-8d95-77938decb67e | 2026-03-10 | Warnings, Adverse reactions | 593YOG76RN |
| Isosulfan Blue | ISOSULFAN BLUE | Eugia US LLC | 42f2d62a-c7f2-4706-87bc-64f3e72d63a9 | 2026-02-20 | Warnings, Adverse reactions | 39N9K8S2A4 |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 593YOG76RN |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 593YOG76RN |
| Uretron D/S | METHENAMINE, SODIUM PHOSPHATE MONOBASIC, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | ea74f1aa-2b4d-4ccf-e053-2995a90abab5 | 2025-12-18 | Warnings, Adverse reactions | 593YOG76RN |
| Isosulfan Blue | ISOSULFAN BLUE | Mylan Institutional LLC | 0391e544-3633-48df-9f3a-ed16183125b1 | 2025-12-15 | Warnings, Adverse reactions | 39N9K8S2A4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.